Latest Trials

EudraCT Number: 2005-002438-37 Sponsor Protocol Number: 2005/VCC/0018(WCTU02) Start Date: 2006-12-07
Sponsor Name: Velindre NHS Trust
Full Title: A randomised phase III clinical trial investigating the effect of FRAGMin® Added to standard Therapy In patients with lung Cancer
Medical condition: Lung cancer
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025044 Lung cancer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-005626-24 Sponsor Protocol Number: 1247 Start Date: 2006-12-07
Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Full Title: PHASE II STUDY ON PEMETREXED IN ADVANCED AND/OR RECURRENT CERVICAL CANCER
Medical condition: advanced or metastatic cervical cancer
Disease: Version SOC Term Classification Code Term Level
6.1 10008342 PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-004398-89 Sponsor Protocol Number: 380104 Start Date: 2006-12-06
Sponsor Name: Medinova AG
Full Title: Comparative Study of the Efficacy of 10 mg Dequalinium Chloride (Fluomizin®) in the Local Treatment of Bacterial Vaginosis
Medical condition: Bacterial Vaginosis
Disease: Version SOC Term Classification Code Term Level
8.1 10004055 Bacterial vaginosis LLT
Population Age: Adults Gender: Female
Trial protocol: DE (Completed) AT (Prematurely Ended) CZ (Completed) SK (Completed)
Trial results: (No results available)
EudraCT Number: 2006-001846-15 Sponsor Protocol Number: CSUC-01/06 Start Date: 2006-12-06
Sponsor Name: InDex Pharmaceuticals AB
Full Title: A placebo-controlled, randomised, double-blind, single dose proof of concept study of Kappaproct, in steroid resistant or steroid dependent patients with ulcerative colitis of mild to moderate degree
Medical condition: Active ulcerative colitis in steroid refractory or steroid dependent patients
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2005-003901-10 Sponsor Protocol Number: 250317BS Start Date: 2006-12-06
Sponsor Name: Neosil Inc.
Full Title: A randomized, placebo controlled, double-blind study to evaluate the efficacy of topical formulations in male subjects with androgenetic alopecia
Medical condition: The study will be performed in male subjects with Norwood/Hamilton grades III - IV, androgenetic alopecia.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2006-005082-19 Sponsor Protocol Number: RB23EZ Start Date: 2006-12-06
Sponsor Name: Research Innovation Services, University of Nottingham
Full Title: Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with recent stroke.
Medical condition: Patients who have hypertension in the context of recent stroke.
Disease: Version SOC Term Classification Code Term Level
8.1 10015488 Essential hypertension LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2005-000474-42 Sponsor Protocol Number: CL2-90652-002 Start Date: 2006-12-06
Sponsor Name: INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
Full Title: Safety and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in hypertensive children having received S 90652 -...
Medical condition: Arterial Hypertension
Disease: Version SOC Term Classification Code Term Level
14.1 10047065 - Vascular disorders 10015488 Essential hypertension PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2006-005143-28 Sponsor Protocol Number: MED.RES.HOS.2006.03.LP Start Date: 2006-12-06
Sponsor Name: Medicinsk Forskning
Full Title: Effects of HMG-CoA-reductase inhibition (atorvastatin) on renal sodium excretion, renal hemodynamics, tubular function and vasoactive hormones in healthy subjects under diet with normal and high so...
Medical condition: Healthy volunteer trial
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: (No results available)
EudraCT Number: 2006-003762-33 Sponsor Protocol Number: 106481 Start Date: 2006-12-06
Sponsor Name: GlaxoSmithKline Biologicals
Full Title: A phase IIIb, double blind, randomised, placebo–controlled, multi–country, multicentre study to assess the safety, reactogenicity and immunogenicity of two doses of GlaxoSmithKline (GSK) Biological...
Medical condition: Primary immunisation of pre–term infants against human rotavirus gastroenteritis (GE)
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
Trial protocol: FR (Completed) PT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2006-004815-24 Sponsor Protocol Number: FM-MYEL-06-01 Start Date: 2006-12-05
Sponsor Name: FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI
Full Title: Bortezomib and dexamethasone treatment before donor lymphocyte infusions for myeloma patients progressing or relapsing after allogeneic transplantation of hematopoietic cells
Medical condition: Myeloma patients progressing or relapsing after allogeneic transplantation
Disease: Version SOC Term Classification Code Term Level
9.1 10028228 Multiple myeloma LLT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe